TNF-alpha Antagonists for AECOPD: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether treatment with antibiotics plus a TNFalpha
antagonist will provide more effective treatment for acute COPD exacerbation compared to the
current standard treatment of antibiotics plus prednisone.